Company news
Alteogen Inc. (KRX:196170) news
Alteogen Inc. news releases on 6ix. Latest, Sep 2, 2026: Alteogen Enters Option and License Agreement with Novartis for Development and Commercialization…
Press releases & updates
Alteogen Enters Option and License Agreement with Novartis for Development and Commercialization of Hybrozyme™-Enabled Subcutaneous Products
September 2, 2026
Alteogen Announces Exclusive License Agreement with a Global Pharmaceutical Company for the Development and Commercialization of a Hybrozyme™-Enabled Subcutaneous Biologic Product
August 5, 2026
Alteogen Showcases ALT-B4's Potential to Transform ADC Development at World ADC Summit 2026
June 10, 2026
Alteogen Receives European Commission Approval for Aflibercept Biosimilar, EYLUXVI® (ALT-L9)
September 17, 2025
Alteogen Receives Positive CHMP Opinion for Aflibercept Biosimilar, 'EYLUXVI® (ALT-L9)'
July 28, 2025